The Fund invests globally, with a bias towards North America, with a primary focus on “Compounders”, companies we believe have the ability to grow earnings per share by 10-15% per year over the long term.

To complement the above approach, we invest in companies where a catalyst, most often improved capital allocation, could unlock shareholder value. We also short sell overpriced securities.